Considering the role of PI3K signaling in the recruitment of MDSCs, regulatory T cells, and expression of PD-L1, appropriate biomarkers might be mutations in the PI3K pathway that are specifically involved in creating an immunosuppressive tumor microenvironment. The gene discussed is PIK3CA; the disease is neoplasm.